BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35406471)

  • 1. Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients.
    Halámková J; Bohovicová L; Pehalová L; Goněc R; Staněk T; Kazda T; Mouková L; Krákorová DA; Kozáková Š; Svoboda M; Demlová R; Kiss I
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
    Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Slaby O; Demlova R; Svoboda M; Kiss I
    Front Oncol; 2020; 10():573394. PubMed ID: 33585194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
    Yang J; Wu F; An H; Gan H
    Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.
    Lee YT; Liu CJ; Hu YW; Teng CJ; Tzeng CH; Yeh CM; Chen TJ; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC; Chen MH; Teng HW; Liu JH; Yen CC
    Medicine (Baltimore); 2015 Jul; 94(26):e1079. PubMed ID: 26131831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of developing second primary malignancies among colorectal cancer patients.
    Du S; Li Y; Sun H; Deng G; Tang S; Zeng F; Zhang B; Cui B
    Aging (Albany NY); 2022 Aug; 14(16):6756-6779. PubMed ID: 36036758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second primary malignancies in colorectal cancer patients.
    Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Krakorova DA; Slaby O; Demlova R; Svoboda M; Kiss I
    Sci Rep; 2021 Feb; 11(1):2759. PubMed ID: 33531585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer.
    Wu M; Huang M; He C; Chen C; Li H; Wang J; Liu M; Fu G; Lei Z; Chu X
    Front Oncol; 2021; 11():650937. PubMed ID: 33777813
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence features of second primary malignancy among gastric cancer survivors, 1992-2012.
    Li S; Luo Y; Hou Q; Chu H; Zheng H
    Transl Cancer Res; 2020 Nov; 9(11):7001-7011. PubMed ID: 35117306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.
    Nandy N; Dasanu CA
    Curr Med Res Opin; 2013 Sep; 29(9):1055-65. PubMed ID: 23777310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy.
    Zhang B; Guo K; Zheng X; Sun L; Shen M; Ruan S
    Front Oncol; 2020; 10():1154. PubMed ID: 32766153
    [No Abstract]   [Full Text] [Related]  

  • 18. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Khanal A; Budhathoki N; Singh VP; Shah BK
    Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.
    Yang J; Li S; Lv M; Wu Y; Chen Z; Shen Y; Wang B; Chen L; Yi M; Yang J
    Onco Targets Ther; 2017; 10():1535-1548. PubMed ID: 28352187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers.
    Halámková J; Bohovicová L; Pehalová L; Kazda T; Goněc R; Staněk T; Mouková L; Adámková Krákorová D; Kozáková Š; Svoboda M; Demlová R; Gabrielová L; Hernychová L; Kiss I
    Sci Rep; 2023 Mar; 13(1):3490. PubMed ID: 36859505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.